RCAS1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of RCAS1 monoclonal antibodies for research focused on understanding RCAS1 protein functions. RCAS1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).RCAS1, or Receptor-Carrier for Apoptosis Stimulating Protein 1, plays a critical role in immune regulation and tumor progression. RCAS1 influences the modulation of apoptosis and has been linked to immune response evasion by cancer cells. Understanding RCAS1 function is essential for developing therapeutic strategies targeting tumor immunity and enhancing cancer treatment efficacy. Research has shown that RCAS1 expression levels correlate with disease progression in various cancer types. Recent studies have highlighted RCAS1's potential as a biomarker for cancer prognosis and treatment response. Ongoing investigations continue to uncover new aspects of RCAS1's role in cellular signaling pathways and immune system regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cancer biology and immunology through precise and reliable experimental results.